Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 709 (USA) (Dr. Novak)
· consented 2013-08-15
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-08-25 (study day 11.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild PYREXIA — outcome: RECOVERED/RESOLVED; onset 2013-08-25 (study day 11.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.